AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

RecruitingPhase 3Ages 18 Years - 65 YearsAllAxsome Therapeutics, Inc.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trial to evaluate the efficacy and safety of AXS-05 compared to placebo and bupropion for smoking cessation in adults.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male or female, aged 18 to 65 (inclusive) Exclusion Criteria: * Unable to comply with study procedures. * Medically inappropriate for study participation in the opinion of the investigator.
๐Ÿ’Š

What it tests

  • AXS-05 (dextromethorphan-bupropion)
  • Bupropion
  • Placebo
๐Ÿ“

Where

26 sites
Clinical Research Site
Little Rock, United States
Clinical Research Site
Lemon Grove, United States
Clinical Research Site
Long Beach, United States
Clinical Research Site
Pomona, United States
Clinical Research Site
DeLand, United States
Clinical Research Site
Jacksonville, United States
Clinical Research Site
Orlando, United States
Clinical Research Site
Tampa, United States

โ€ฆand 18 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy